HALO - Halozyme Therapeutics, Inc.
Price:
--
--
|
CONSENSUS:
Buy
DETAILS
|
PRICE TARGET:
$75.00
DETAILS
HIGH:
$95.00
LOW:
$56.00
MEDIAN:
$75.00
CONSENSUS:
$75.00
UPSIDE:
9.78%
Institutional Holders (13F)
| GURU | SHARES | VALUE | WEIGHT % | SHARES CHG | ACTION |
|---|---|---|---|---|---|
| Greenblatt | 746,841 | $48.3M | 0.1% | +307,133 | INCREASED |
| Dalio | 511,429 | $33.1M | 0.1% | -50,148 | DECREASED |
| Cooperman | 20,900 | $1.4M | 0.0% | -1,628,566 | DECREASED |
Insider Trading
| DATE | INSIDER | TITLE | TYPE | SHARES | PRICE | VALUE |
|---|---|---|---|---|---|---|
| 2026-05-12 | Torley Helen | director, officer: PRESIDENT AND CEO | SELL | 100 | $67.85 | $7K |
| 2026-05-12 | Torley Helen | director, officer: PRESIDENT AND CEO | SELL | 1,398 | $70.29 | $98K |
| 2026-05-11 | Torley Helen | director, officer: PRESIDENT AND CEO | SELL | 9,725 | $64.63 | $629K |
| 2026-05-13 | Torley Helen | director, officer: PRESIDENT AND CEO | SELL | 3,350 | $68.88 | $231K |
| 2026-05-12 | Torley Helen | director, officer: PRESIDENT AND CEO | SELL | 5,900 | $72.15 | $426K |
| 2026-05-13 | Torley Helen | director, officer: PRESIDENT AND CEO | SELL | 3,950 | $69.79 | $276K |
| 2026-05-11 | Torley Helen | director, officer: PRESIDENT AND CEO | SELL | 6,700 | $66.33 | $444K |
| 2026-05-13 | Torley Helen | director, officer: PRESIDENT AND CEO | SELL | 600 | $70.81 | $42K |
| 2026-05-11 | Torley Helen | director, officer: PRESIDENT AND CEO | M-Exempt | 20,000 | $12.07 | $241K |
| 2026-05-12 | Torley Helen | director, officer: PRESIDENT AND CEO | SELL | 2,800 | $73.12 | $205K |
| 2026-05-12 | Torley Helen | director, officer: PRESIDENT AND CEO | SELL | 9,802 | $71.37 | $700K |
| 2026-05-13 | Torley Helen | director, officer: PRESIDENT AND CEO | SELL | 2,100 | $68.10 | $143K |
| 2026-05-11 | Torley Helen | director, officer: PRESIDENT AND CEO | SELL | 3,575 | $65.46 | $234K |
| 2026-05-12 | Torley Helen | director, officer: PRESIDENT AND CEO | M-Exempt | 20,000 | $12.07 | $241K |
| 2026-05-13 | Torley Helen | director, officer: PRESIDENT AND CEO | M-Exempt | 10,000 | $12.07 | $121K |
| 2026-05-05 | Posard Matthew L. | director | A-Award | 6,040 | $65.87 | $398K |
| 2026-05-05 | Krishnan Mahesh | director | A-Award | 3,796 | -- | -- |
| 2026-05-05 | Krishnan Mahesh | director | A-Award | 6,040 | $65.87 | $398K |
| 2026-05-05 | Lang James Paul | director | A-Award | 3,796 | -- | -- |
| 2026-05-05 | Henderson Jeffrey William | director | A-Award | 6,040 | $65.87 | $398K |
| 2026-05-05 | DUNCAN BARBARA GAYLE | director | A-Award | 3,796 | -- | -- |
| 2026-05-05 | DUNCAN BARBARA GAYLE | director | A-Award | 6,040 | $65.87 | $398K |
| 2026-05-05 | Connaughton Bernadette | director | A-Award | 6,040 | $65.87 | $398K |
| 2026-05-05 | Henderson Jeffrey William | director | A-Award | 3,796 | -- | -- |
| 2026-05-05 | Posard Matthew L. | director | A-Award | 3,796 | -- | -- |